お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
970307

経カテーテル大動脈弁留置術 (TAVI):医療機器パイプライン評価 (2020年)

Transcatheter Aortic Valve Implantation (TAVI) - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 138 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
経カテーテル大動脈弁留置術 (TAVI):医療機器パイプライン評価 (2020年)
出版日: 2020年10月31日
発行: GlobalData
ページ情報: 英文 138 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、経カテーテル大動脈弁留置術 (TAVI) に向けた医療機器のパイプライン動向を調査し、手術および製品の概要、開発中の製品の概要、参加事業者、開発段階、承認予定、ライセンシング&コラボレーションの状況、臨床試験の状況、企業および企業間の動向、取り組みなどをまとめています。

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • 開発段階別
  • 地域別
  • 規制経路別
  • 承認予定日別
  • 進行中の臨床試験

第4章 開発中の製品:企業別

第5章 企業・製品のプロファイル

  • Aegis SurgicalLimited
  • Anteris TechnologiesLtd
  • AorTx, inc.
  • Arbor Surgical Technologies, inc.
  • Boston ScientificCorp
  • Carena Healthcare Ltd
  • Clemson University
  • Colibri Heart Valve LLC
  • Daidalos Solutions BV
  • Direct Flow Medical Inc
  • DSM Dyneema BV
  • Dura LLC
  • Edwards Lifesciences Corp
  • Foldax Inc
  • HLT, inc.
  • JC Medical, inc.
  • JenaValve Technology GmbH
  • Mayo Clinic
  • Medtronic Plc
  • MicroPort Scientific Corp
  • NVTAG
  • Peijia Medical Ltd
  • PolyNova Cardiovascular Inc
  • RegenaGraft
  • ReValve Med Inc
  • SAS Cormove
  • St. Jude Medical LLC
  • Stony Brook University
  • Symetis SA
  • The University of British Columbia
  • Thubrikar Aortic Valve, inc.
  • University College London
  • University of California San Francisco
  • University of Cambridge
  • University of Iowa
  • Vascular Concepts Ltd
  • Venus MedTech
  • Xeltis AG

第6章 近年の展開

  • Apollo Hospitals:非高齢者の患者に対する経カテーテル大動脈弁置換術に成功
  • 抗石灰化の比較研究
  • BioCardia:訴訟資金調達を発表
  • Edwards :COVID-19への集中のため僧帽弁・三尖弁試験への登録を一時停止、など

第7章 付録

図表

List of Tables

List of Tables

  • Table 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
  • Table 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
  • Table 3: Transcatheter Aortic Valve Implantation (T

List of Figures

List of Figures

  • Figure 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
  • Figure 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
  • Figure 3: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
  • Figure 4: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
  • Figure 5: Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials
目次
Product Code: GDME1012EPD

GlobalData's Medical Devices sector report, "Transcatheter Aortic Valve Implantation (TAVI) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transcatheter Aortic Valve Implantation (TAVI) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transcatheter Aortic Valve Implantation, also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Aortic Valve Implantation (TAVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Aortic Valve Implantation (TAVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Aortic Valve Implantation (TAVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transcatheter Aortic Valve Implantation (TAVI) Overview

3 Products under Development

  • 3.1 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
  • 3.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
  • 3.3 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
  • 3.4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
  • 3.5 Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials

4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products under Development by Companies

  • 4.1 Transcatheter Aortic Valve Implantation (TAVI) Companies - Pipeline Products by Stage of Development
  • 4.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development

5 Transcatheter Aortic Valve Implantation (TAVI) Companies and Product Overview

  • 5.1 Aegis Surgical Limited Company Overview
    • 5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Anteris Technologies Ltd Company Overview
    • 5.2.1 Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 AorTx, Inc. Company Overview
    • 5.3.1 AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Arbor Surgical Technologies, Inc. Company Overview
    • 5.4.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Boston Scientific Corp Company Overview
    • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Carena Healthcare Ltd Company Overview
    • 5.6.1 Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Clemson University Company Overview
    • 5.7.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Colibri Heart Valve LLC Company Overview
    • 5.8.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Daidalos Solutions BV Company Overview
    • 5.9.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Direct Flow Medical Inc (Inactive) Company Overview
    • 5.10.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 DSM Dyneema BV Company Overview
    • 5.11.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Dura LLC Company Overview
    • 5.12.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Edwards Lifesciences Corp Company Overview
    • 5.13.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Foldax Inc Company Overview
    • 5.14.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 HLT, Inc. Company Overview
    • 5.15.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 JC Medical, Inc. Company Overview
    • 5.16.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 JenaValve Technology GmbH Company Overview
    • 5.17.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Mayo Clinic Company Overview
    • 5.18.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Medtronic Plc Company Overview
    • 5.19.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 MicroPort Scientific Corp Company Overview
    • 5.20.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 NVT AG Company Overview
    • 5.21.1 NVT AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Peijia Medical Ltd Company Overview
    • 5.22.1 Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 PolyNova Cardiovascular Inc Company Overview
    • 5.23.1 PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 RegenaGraft Company Overview
    • 5.24.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 ReValve Med Inc Company Overview
    • 5.25.1 ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 SAS Cormove Company Overview
    • 5.26.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 St. Jude Medical LLC Company Overview
    • 5.27.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Stony Brook University Company Overview
    • 5.28.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Symetis SA Company Overview
    • 5.29.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 The University of British Columbia Company Overview
    • 5.30.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Thubrikar Aortic Valve, Inc. Company Overview
    • 5.31.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 University College London Company Overview
    • 5.32.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 University of California San Francisco Company Overview
    • 5.33.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 University of Cambridge Company Overview
    • 5.34.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 University of Iowa Company Overview
    • 5.35.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 Vascular Concepts Ltd Company Overview
    • 5.36.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 Venus MedTech Company Overview
    • 5.37.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 Xeltis AG Company Overview
    • 5.38.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview

6 Transcatheter Aortic Valve Implantation (TAVI)- Recent Developments

  • 6.1 Jun 24, 2020: Apollo Hospitals, Indore successfully performs Transcatheter Aortic Valve Replacement surgery on a nonagenarian patient.
  • 6.2 May 19, 2020: Anti-calcification comparison study
  • 6.3 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
  • 6.4 Mar 28, 2020: Edwards pauses enrollments in pivotal mitral, tricuspid trials in response to hospitals' focus on COVID-19
  • 6.5 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
  • 6.6 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
  • 6.7 Feb 18, 2020: Medtronic reports third quarter financial results 2020
  • 6.8 Feb 17, 2020: Hershey Medical Center becomes first in region to offer latest Edwards Sapien heart valve device
  • 6.9 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
  • 6.10 Jan 22, 2020: First-in-human SAVR trial begins Q1 2020
  • 6.11 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
  • 6.12 Jan 09, 2020: JenaValve Transcatheter Aortic Valve Replacement (TAVR) System designated by FDA as breakthrough device
  • 6.13 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
  • 6.14 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
  • 6.15 Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.